Clinical Trial Update: Heme Arginate in Functional Magnetic Resonance Imaging (fMRI) [Phase 2]

View source ↗

Summary

An update on a Phase 2 clinical trial evaluating Heme Arginate for ischemia-reperfusion injury using functional MRI; current trial status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemia-reperfusion Injury

Drugs mentioned

• Heme Arginate (heme arginate)

Snippet

Sponsor: MWolzt | Conditions: Ischemia-reperfusion Injury | Phase 2 | Status: UNKNOWN